Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0KRTEV)
| ADC Name |
B43-genistein
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
B43-genistein
Click to Show/Hide
|
|||||
| Organization |
University of Minnesota (Originator);Parker Hughes Cancer Center (Originator)
|
|||||
| Drug Status |
Phase 1 (discontinued)
|
|||||
| Antibody Name |
Anti-CD19 antibody
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
Genistein
|
Payload Info | ||||
| Payload Target |
isoflavone tyrosine kinase
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random Lysines
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC